ES2044410T3 - Procedimiento para la liberacion prolongada de somatotropina. - Google Patents

Procedimiento para la liberacion prolongada de somatotropina.

Info

Publication number
ES2044410T3
ES2044410T3 ES90202047T ES90202047T ES2044410T3 ES 2044410 T3 ES2044410 T3 ES 2044410T3 ES 90202047 T ES90202047 T ES 90202047T ES 90202047 T ES90202047 T ES 90202047T ES 2044410 T3 ES2044410 T3 ES 2044410T3
Authority
ES
Spain
Prior art keywords
somatotropin
procedure
prolonged release
liberation
article
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90202047T
Other languages
English (en)
Inventor
Michael Joseph Azain
Kenneth Eugene Eigenberg
Thomas Richard Kasser
Milton Jerome Sabacky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Co
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ES2044410T3 publication Critical patent/ES2044410T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Detergent Compositions (AREA)
  • Silicon Polymers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA ADMINISTRACION LIBRE PROLONGADA DE SOMATOTROPIN A UN ANIMAL DOMESTICO, PRODUCTOR DE COMIDA, ES PROVISTA POR LA IMPLANTACION PARENTERAL DE UN ARTICULO FORMADO QUE COMPRENDE UN CUERPO SOLIDO DE SOMATOTROPIN COMPACTADO, QUE ESTA LIBRE DE AGLUTINANTES Y POLIMEROS DE MATRIZ EN CANTIDADES SUFICIENTES PARA TENER UN EFECTO SUSTANCIAL EN LA LIBERACION DEL SOMATOTROPIN, Y QUE OPCIONALMENTE TIENE UNA CAPA DE BARRERA INHIBIDORA DE LIBERACION QUE CUBRE EL ARTICULO, EXCEPTO POR AL MENOS UNA SUPERFICIE DE LIBERACION DESCUBIERTA.
ES90202047T 1987-03-16 1988-03-15 Procedimiento para la liberacion prolongada de somatotropina. Expired - Lifetime ES2044410T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2609587A 1987-03-16 1987-03-16
US07/146,381 US4863736A (en) 1987-03-16 1988-02-03 Somatotropin prolonged release

Publications (1)

Publication Number Publication Date
ES2044410T3 true ES2044410T3 (es) 1994-01-01

Family

ID=26700778

Family Applications (2)

Application Number Title Priority Date Filing Date
ES90202047T Expired - Lifetime ES2044410T3 (es) 1987-03-16 1988-03-15 Procedimiento para la liberacion prolongada de somatotropina.
ES88870047T Expired - Lifetime ES2053816T3 (es) 1987-03-16 1988-03-15 Liberacion prolongada de somatotropina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES88870047T Expired - Lifetime ES2053816T3 (es) 1987-03-16 1988-03-15 Liberacion prolongada de somatotropina.

Country Status (24)

Country Link
US (1) US4863736A (es)
EP (2) EP0283458B1 (es)
JP (1) JP2664398B2 (es)
KR (1) KR900006886B1 (es)
CN (1) CN1051716C (es)
AT (2) ATE77558T1 (es)
AU (1) AU609456B2 (es)
BG (1) BG83325A (es)
BR (1) BR8801163A (es)
CA (1) CA1322329C (es)
DE (3) DE3883254T2 (es)
DK (1) DK139288A (es)
ES (2) ES2044410T3 (es)
FI (1) FI881219A (es)
GR (1) GR3005504T3 (es)
HU (1) HU208403B (es)
IE (2) IE66927B1 (es)
IL (1) IL85742A (es)
NO (1) NO881131L (es)
NZ (1) NZ223878A (es)
PL (1) PL161857B1 (es)
PT (1) PT86978B (es)
RU (1) RU2087155C1 (es)
YU (1) YU51888A (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US5137669A (en) * 1988-03-02 1992-08-11 Endocon, Inc. Manufacture of partially fused peptide pellet
EP0353045B1 (en) * 1988-07-26 1995-11-15 Rutgers, The State University of New Jersey Devices and methods for growth promotion in poultry roasters
DK173142B1 (da) * 1988-08-24 2000-02-07 Natinco Nv Fremgangsmåde til forbedring af kødkvaliteten og foderomsætningseffektiviteten for grise
US5637566A (en) * 1988-08-24 1997-06-10 Southern Cross Biotech Pty. Ltd. Method of improving carcass quality by administering growth hormone
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5182369A (en) * 1990-02-28 1993-01-26 Monsanto Company Method for purifying somatotropin monomers
US5232708A (en) * 1990-06-20 1993-08-03 Monsanto Company Coated veterinary implants
US5156851A (en) * 1990-06-20 1992-10-20 Monsanto Company Coated veterinary implants
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
AU660290B2 (en) * 1990-08-09 1995-06-22 Endocon, Inc. Multiple drug delivery system
US5169834A (en) * 1990-11-30 1992-12-08 American Cyanamid Company Compositions and method for reducing vial breakage during lyophilization
US5801141A (en) * 1991-06-24 1998-09-01 American Cyanamid Company Implant compositions containing a biologically active protein, peptide or polypeptide
ATE135565T1 (de) * 1991-06-24 1996-04-15 American Cyanamid Co Implantationzusammensetzungen, die biologisch aktive proteine, peptide oder polypeptide enthalten
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
SE9303068D0 (sv) * 1993-09-21 1993-09-21 Kabi Pharmacia Ab New use
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
DE69528450T2 (de) * 1994-02-18 2003-01-23 Solidose L L C Impfung von tieren mit getrockneten pelletierten biologischen materialien
US5633000A (en) * 1994-06-23 1997-05-27 Axxia Technologies Subcutaneous implant
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5582591A (en) * 1994-09-02 1996-12-10 Delab Delivery of solid drug compositions
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
US5837276A (en) 1994-09-02 1998-11-17 Delab Apparatus for the delivery of elongate solid drug compositions
FR2756493B1 (fr) * 1996-12-02 2001-04-13 Delab Dispositif d'administration locale de formulations solides ou semi-solides
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
GB2326825A (en) * 1997-04-10 1999-01-06 William Leslie Porter Bolus for supplying biologically beneficial substances to ruminant animals
AU725882B2 (en) * 1997-06-27 2000-10-26 Monsanto Technology Llc Accelerating animal hoof growth with somatotropin
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
FR2770134B1 (fr) * 1998-10-28 2002-06-07 Delab Formulations solides ou semi-solides pour administration locale
US6488649B1 (en) 1998-11-24 2002-12-03 Edward M. Lichten Implant device
US6238706B1 (en) 1999-05-06 2001-05-29 Grofish L.L.C. Method of stimulating growth in aquatic animals using growth hormones
WO2003075887A1 (en) 2002-03-04 2003-09-18 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Sustained release drug formulations containing a carrier peptide

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517513A (en) * 1943-02-27 1950-08-01 Vaernet Carl Pharmaceutical preparation for implantation
GB885798A (en) * 1958-12-06 1961-12-28 Organon Labor Ltd Preparations of the growth hormone
US4164560A (en) * 1977-01-05 1979-08-14 Folkman Moses J Systems for the controlled release of macromolecules
US4452775A (en) * 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
ES8702440A1 (es) 1984-10-04 1986-12-16 Monsanto Co Un procedimiento para la preparacion de una composicion de polipeptido inyectable sustancialmente no acuosa.
US5037806A (en) 1985-02-22 1991-08-06 Monsanto Company Biologically active method using somatotropins
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
IL79681A (en) * 1985-08-12 1991-06-10 Int Minerals & Chem Corp Transition metal complexes of growth hormones and their prolonged release compositions
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation
US4765980A (en) * 1986-04-28 1988-08-23 International Minerals & Chemical Corp. Stabilized porcine growth hormone
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo

Also Published As

Publication number Publication date
KR900006886B1 (ko) 1990-09-24
EP0283458B1 (en) 1992-06-24
IE62486B1 (en) 1995-02-08
PL161857B1 (pl) 1993-08-31
RU2087155C1 (ru) 1997-08-20
PT86978A (en) 1988-04-01
US4863736A (en) 1989-09-05
YU51888A (en) 1990-06-30
EP0283458A3 (en) 1988-12-07
EP0283458A2 (en) 1988-09-21
IE930017L (en) 1988-09-16
IL85742A (en) 1993-06-10
DE3883254D1 (de) 1993-09-16
ATE92769T1 (de) 1993-08-15
IE880752L (en) 1988-09-16
DE3872279T2 (de) 1993-01-07
NO881131L (no) 1988-09-19
ATE77558T1 (de) 1992-07-15
EP0403032A2 (en) 1990-12-19
IL85742A0 (en) 1988-08-31
HU208403B (en) 1993-10-28
FI881219A (fi) 1988-09-17
NO881131D0 (no) 1988-03-15
AU609456B2 (en) 1991-05-02
PL271219A1 (en) 1989-07-10
JPS63277632A (ja) 1988-11-15
IE66927B1 (en) 1996-02-07
EP0403032B1 (en) 1993-08-11
ES2053816T3 (es) 1994-08-01
DE3883254T2 (de) 1993-12-16
DE3872279D1 (de) 1992-07-30
PT86978B (pt) 1992-06-30
NZ223878A (en) 1990-10-26
DE3883254A1 (es) 1993-09-16
AU1311088A (en) 1988-09-15
DK139288A (da) 1988-09-17
BG83325A (bg) 1993-12-24
CA1322329C (en) 1993-09-21
DK139288D0 (da) 1988-03-15
GR3005504T3 (es) 1993-06-07
KR890012668A (ko) 1989-09-18
CN88101301A (zh) 1988-10-05
HUT46234A (en) 1988-10-28
EP0403032A3 (en) 1990-12-27
CN1051716C (zh) 2000-04-26
JP2664398B2 (ja) 1997-10-15
FI881219A0 (fi) 1988-03-15
BR8801163A (pt) 1988-10-18

Similar Documents

Publication Publication Date Title
ES2044410T3 (es) Procedimiento para la liberacion prolongada de somatotropina.
ES2030736T3 (es) Articulo termo-recuperable.
TW336885B (en) Composite fuel element for smoking articles
CO4870741A1 (es) Conjugados mejorados de interferon - polimero
DE3650693D1 (de) Mit Aziridin behandelte Gegenstände
ES2039609T3 (es) Un anestesico.
MX9203557A (es) Una forma de dosis para suministrar el farmaco benefico verapamil.
FI865227A (fi) Foerfarande foer framstaellning av ett depot-preparat.
FR2385398B1 (es)
ES2077749T3 (es) Preparacion de alfa-olefina por etenolisis.
ES2046246T3 (es) Composicion terapeutica para combatir el sida.
HU9301797D0 (en) Utilization of il-4 for producing pharmaceutical preparatives improving immunoreaction
IT8921837A0 (it) Composizione di combustibile ad elevato contenuto energetico, contenete quadriciclano.
DE3780239D1 (de) Licht emittierende diode mit doppelter heterostruktur.
ES2037171T3 (es) Cierre de palometa.
FI843204A (fi) Renat, detoxifierat endotoxin.
IT8822296A0 (it) Composizione di combustibile ad elevato contenuto energetico.
EP0178676A3 (en) Antigenic peptide compounds
KR920003992A (ko) 백일해, 디프테리아, 파상풍 및 b형 간염의 동시예방을 위한 혼합백신
SU1714992A2 (ru) Секция механизированной крепи

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 403032

Country of ref document: ES